
Mechanisms of transcriptional regulation by WT1 (Wilms’ tumour 1)
Author(s) -
Eneda Toska,
Stefan G. E. Roberts
Publication year - 2014
Publication title -
biochemical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.706
H-Index - 265
eISSN - 1470-8728
pISSN - 0264-6021
DOI - 10.1042/bj20131587
Subject(s) - biology , regulator , zinc finger , transcription factor , gene isoform , suppressor , gene , oncogene , transcriptional regulation , master regulator , zinc finger transcription factor , microbiology and biotechnology , tumor suppressor gene , wilms' tumor , regulation of gene expression , translation (biology) , computational biology , cancer research , genetics , messenger rna , carcinogenesis , cell cycle
The WT1 (Wilms' tumour 1) gene encodes a zinc finger transcription factor and RNA-binding protein that direct the development of several organs and tissues. WT1 manifests both tumour suppressor and oncogenic activities, but the reasons behind these opposing functions are still not clear. As a transcriptional regulator, WT1 can either activate or repress numerous target genes resulting in disparate biological effects such as growth, differentiation and apoptosis. The complex nature of WT1 is exemplified by a plethora of isoforms, post-translational modifications and multiple binding partners. How WT1 achieves specificity to regulate a large number of target genes involved in diverse physiological processes is the focus of the present review. We discuss the wealth of the growing molecular information that defines our current understanding of the versatility and utility of WT1 as a master regulator of organ development, a tumour suppressor and an oncogene.